Article

Navigating the IRA Impact: Change Implementation for Value-Based Account Strategies

The Inflation Reduction Act (IRA) of 2022 represents one of the most significant shifts in U.S. pharmaceutical policy...

The healthcare landscape continues to evolve rapidly, with one of the most significant trends being the ongoing consolidation...

As the healthcare landscape undergoes seismic shifts, market access leaders in the biopharmaceutical industry find themselves at the...

If there is one constant every year that companies face, it is Change. Whether it’s new strategic initiatives...

The Promise of Personalized Medicine 2025: A patient walks into her doctor’s office. Within minutes, a comprehensive genetic...

The Complexity of Modern Pharma Organizations As we approach 2025, pharmaceutical companies are grappling with increasingly complex organizational...

The Imperative of Measurable Change As the pharmaceutical industry continues to evolve at a breakneck pace, organizations are...

Organizational change has become a constant in the biopharmaceutical industry, with companies continually adapting to evolving market dynamics,...

Learn how a well-executed "team jump-start" can help leaders reduce anxiety, boost team adaptation, and maintain productivity during...

As L&D leaders in pharma, biotech, and medical devices, we have a unique opportunity to bolster commercial excellence...

Empowering Commercial Excellence: HR’s Strategic Role in Summer Advancement As HR leaders in pharma, biotech, and medical device,...

As commercial leaders in pharma, biotech, and medical devices, we often face a unique challenge during the summer...